 Connection
Matthew Greenhawt to Injections, Intramuscular
This is a "connection" page, showing publications Matthew Greenhawt has written about Injections, Intramuscular.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.393 |
|
|
|
-
Waserman S, Avilla E, Ben-Shoshan M, Rosenfield L, Adcock AB, Greenhawt M. Epinephrine Autoinjectors: New Data, New?Problems. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1180-1191.
Score: 0.565
-
Greenhawt M. Is epinephrine truly lifesaving, and can we prove this? Ann Allergy Asthma Immunol. 2023 08; 131(2):279-282.
Score: 0.209
-
Shaker M, Greenhawt M. Cost-Effectiveness of Stock Epinephrine Autoinjectors on Commercial Aircraft. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2270-2276.
Score: 0.160
-
Greenhawt M, Gupta RS, Meadows JA, Pistiner M, Spergel JM, Camargo CA, Simons FER, Lieberman PL. Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel Consensus. J Allergy Clin Immunol Pract. 2019 04; 7(4):1148-1156.e5.
Score: 0.156
-
Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
Score: 0.156
-
Shaker M, Toy D, Lindholm C, Low J, Reigh E, Greenhawt M. Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):2143-2145.e4.
Score: 0.147
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|